EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 6 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $191,000 | – | 19,012 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 400,000 | $4,008,000 | 1.47% |
| 683 Capital Management, LLC | 600,000 | $6,012,000 | 0.46% |
| CVI Holdings, LLC | 367,552 | $3,687,000 | 0.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $2,004,000 | 0.26% |
| SkyView Investment Advisors, LLC | 71,773 | $719,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,999 | $10,020,000 | 0.20% |
| GLAZER CAPITAL, LLC | 1,022,411 | $10,245,000 | 0.19% |
| METEORA CAPITAL, LLC | 56,076 | $562,000 | 0.14% |
| Cowen Investment Management LLC | 50,000 | $501,000 | 0.11% |
| First Trust Capital Management L.P. | 208,598 | $2,090,000 | 0.10% |